Nanocarriers for methotrexate delivery/codelivery in the frame of cancer diagnostics and treatment: a review

Nanocarriers for methotrexate delivery/codelivery in the frame of cancer diagnostics and treatment: a review

Cancer is one of the most life-threatening family of diseases that cause death worldwide. As a highly researched and successful therapeutic agent, methotrexate (MTX) treats many solid tumours, hematologic malignancies, and autoimmune illnesses. Despite many benefits, methotrexate induces drug resist...

Full description

Bibliographic Details
Main Authors: Mahwash Mukhtar, Amanda-Lee Ezra Manicum, Masoumeh Shojaei Barjouei, Rahime Eshaghi Malekshah, Razieh Behzadmehr, Abbas Rahdar, Suresh Ghotekar, Francesco Baino
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Biomaterials Science
Subjects:
cancer therapy
methotrexate
nanoparticles
immune system
drug delivery
Online Access:https://www.frontiersin.org/articles/10.3389/fbiom.2023.1200670/full

Internet

https://www.frontiersin.org/articles/10.3389/fbiom.2023.1200670/full

Similar Items